CymitQuimica logo

CAS 1313363-54-0

:

CGM097

Description:
CGM097, with the CAS number 1313363-54-0, is a small molecule that has been investigated primarily for its potential therapeutic applications, particularly in the field of oncology. It functions as a selective inhibitor of certain protein kinases, which are crucial in regulating various cellular processes, including cell growth and division. The compound is characterized by its ability to interfere with specific signaling pathways that are often dysregulated in cancer cells, thereby inhibiting tumor proliferation. CGM097 has shown promise in preclinical studies, demonstrating efficacy against certain cancer types. Its chemical structure includes functional groups that contribute to its binding affinity and selectivity for target kinases. Additionally, the compound's pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are essential for determining its suitability for clinical use. Ongoing research aims to further elucidate its mechanism of action and potential side effects, as well as to optimize its formulation for therapeutic applications.
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
  • NVP-CGM097

    CAS:
    NVP-CGM097
    Purity:≥98%
    Molecular weight:659.26g/mol

    Ref: 54-BUP04649

    1mg
    120.00€
    5mg
    300.00€
    10mg
    486.00€
    25mg
    727.00€
    50mg
    938.00€
    100mg
    1,196.00€
  • NVP-CGM097

    CAS:
    <p>NVP-CGM097 (CGM097) is an effective and specific MDM2 inhibitor (IC50: 1.7 nM for hMDM2).</p>
    Formula:C38H47ClN4O4
    Purity:98.77%
    Color and Shape:Solid
    Molecular weight:659.26
  • CGM-097

    CAS:
    <p>CGM-097 is a potent antitumor agent that targets senescent cells. It is a monoclonal antibody that specifically binds to the apoptosis protein, which prevents its translocation to the nucleus and induces apoptosis. CGM-097 has been shown to have potent antitumor activity in vivo models of melanoma and BCR-ABL positive leukemia. CGM-097 has been shown to be chemically stable in vitro and in vivo, with no significant toxicity observed at higher doses. The drug’s synergistic effects are due to its ability to target both tumor cells and their surrounding microenvironment, as well as upregulating genes involved in cell death and immune response.</p>
    Formula:C38H47ClN4O4
    Purity:Min. 95%
    Molecular weight:659.26 g/mol

    Ref: 3D-NCC36354

    25mg
    1,124.00€
    50mg
    1,563.00€
    100mg
    2,437.00€